LOGIN
Effectiveness and safety of rivaroxaban or low-molecular-weight heparin in non-major surgery
December 2024
Effectiveness and safety of rivaroxaban or low-molecular-weight heparin in non-major surgery
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Effectiveness and safety of rivaroxaban or low-molecular-weight heparin in non-major orthopedic surgery: a meta-analysis of randomized controlled trials.
J Orthop Surg Res . 2024 Sep 28;19(1):609.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Five randomized controlled trials, including 5101 patients undergoing non-major orthopedic surgery, were analyzed to compare rivaroxaban with LMWH for thromboprophylaxis. Pooled outcomes of interest included venous thromboembolism (VTE), deep vein thrombosis (DVT), pulmonary embolism (PE), overall bleeding events, and major bleeding events. The results showed no significant difference between riva...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.